132 related articles for article (PubMed ID: 22292507)
1. Immunohistochemical study of nuclear factor-κB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU.
Hatata T; Higaki K; Tatebe S; Shomori K; Ikeguchi M
Dis Esophagus; 2012; 25(8):716-22. PubMed ID: 22292507
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nuclear factor-κB activity by small interfering RNA in esophageal squamous cell carcinoma cell lines.
Hatata T; Higaki K; Nanba E; Tatebe S; Ikeguchi M
Oncol Rep; 2011 Sep; 26(3):659-64. PubMed ID: 21617867
[TBL] [Abstract][Full Text] [Related]
3. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
Tian F; Zhang C; Tian W; Jiang Y; Zhang X
Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
[TBL] [Abstract][Full Text] [Related]
5. [Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-kappaB signaling pathway].
Tian F; Song M; Xu PR; Liu HT; Xue LX
Ai Zheng; 2008 Jun; 27(6):566-70. PubMed ID: 18570726
[TBL] [Abstract][Full Text] [Related]
6. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
Tu Y; Tan F; Zhou J; Pan J
Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
[TBL] [Abstract][Full Text] [Related]
7. A small interfering RNA targeting NF-κB p65 alone or combined with 5-FU inhibits growth of esophageal squamous cell carcinoma in nude mice.
Tian F; Fan T; Jiang Y; Zhang X; Wang X
Pathol Res Pract; 2012 Jan; 208(1):32-8. PubMed ID: 22186294
[TBL] [Abstract][Full Text] [Related]
8. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
9. Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation.
Izzo JG; Wu X; Wu TT; Huang P; Lee JS; Liao Z; Lee JH; Bhutani MS; Hofstetter W; Maru D; Hung MC; Ajani JA
Dis Esophagus; 2009; 22(2):127-32. PubMed ID: 19021681
[TBL] [Abstract][Full Text] [Related]
10. Flotillin-1 promotes tumor necrosis factor-α receptor signaling and activation of NF-κB in esophageal squamous cell carcinoma cells.
Song L; Gong H; Lin C; Wang C; Liu L; Wu J; Li M; Li J
Gastroenterology; 2012 Oct; 143(4):995-1005.e12. PubMed ID: 22732732
[TBL] [Abstract][Full Text] [Related]
11. Enhanced sensitivity to chemotherapy in esophageal cancer through inhibition of NF-kappaB.
Li J; Minnich DJ; Camp ER; Brank A; Mackay SL; Hochwald SN
J Surg Res; 2006 May; 132(1):112-20. PubMed ID: 16337965
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Minato T; Yamamoto Y; Seike J; Yoshida T; Yamai H; Takechi H; Yuasa Y; Furukita Y; Goto M; Bando Y; Tangoku A
Ann Surg Oncol; 2013 Jan; 20(1):209-17. PubMed ID: 22847125
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA.
Tian F; Zang WD; Hou WH; Liu HT; Xue LX
Acta Biochim Biophys Sin (Shanghai); 2006 May; 38(5):318-26. PubMed ID: 16680372
[TBL] [Abstract][Full Text] [Related]
14. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
[TBL] [Abstract][Full Text] [Related]
15. Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma.
Izzo JG; Malhotra U; Wu TT; Ensor J; Luthra R; Lee JH; Swisher SG; Liao Z; Chao KS; Hittelman WN; Aggarwal BB; Ajani JA
J Clin Oncol; 2006 Feb; 24(5):748-54. PubMed ID: 16401681
[TBL] [Abstract][Full Text] [Related]
16. The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma.
Zhang Y; Molavi O; Su M; Lai R
BMC Cancer; 2014 Oct; 14():791. PubMed ID: 25355139
[TBL] [Abstract][Full Text] [Related]
17. Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor-κB signaling in esophageal squamous cell carcinoma.
Wu J; Chen K; Zhang F; Jin J; Zhang N; Li D; Ying L; Chen W; Yu H; Mao W; Su D
Cancer Med; 2017 Jun; 6(6):1353-1361. PubMed ID: 28440057
[TBL] [Abstract][Full Text] [Related]
18. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic relevance of p21WAF1 in stage III esophageal squamous cell carcinoma.
Liu J; Hu Y; Hu W; Xie X; Ela Bella A; Fu J; Rao D
Dis Esophagus; 2012 Jan; 25(1):67-71. PubMed ID: 21689205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
